Yildiz, H. Et Al. 2021. Evaluation serum levels of YKL-40, Periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma. HEART & LUNG , vol.50, no.1 , 177-183.

Yildiz, H., Alp, H. H., Sünnetçioğlu, A., Ekin, S., & Mermit, Ç., (2021). Evaluation serum levels of YKL-40, Periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma. HEART & LUNG , vol.50, no.1, 177-183.

Yildiz, Hanifi Et Al. "Evaluation serum levels of YKL-40, Periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma," HEART & LUNG , vol.50, no.1, 177-183, 2021

Yildiz, Hanifi Et Al. "Evaluation serum levels of YKL-40, Periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma." HEART & LUNG , vol.50, no.1, pp.177-183, 2021

Yildiz, H. Et Al. (2021) . "Evaluation serum levels of YKL-40, Periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma." HEART & LUNG , vol.50, no.1, pp.177-183.

@article{article, author={Hanifi Yıldız Et Al. }, title={Evaluation serum levels of YKL-40, Periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma}, journal={HEART & LUNG}, year=2021, pages={177-183} }